Source:http://linkedlifedata.com/resource/pubmed/id/21050800
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2010-11-26
|
| pubmed:abstractText |
Both the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) have MIC clinical breakpoints (CBPs) for fluconazole (FLU) and Candida. EUCAST CBPs are species-specific, and apply only to C. albicans, C. tropicalis and C. parapsilosis, while CLSI CBPs apply to all species. We reassessed the CLSI CBPs for FLU and Candida in light of recent data.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1532-2084
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
13
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
180-95
|
| pubmed:meshHeading |
pubmed-meshheading:21050800-Candida,
pubmed-meshheading:21050800-Candidiasis,
pubmed-meshheading:21050800-Drug Resistance, Fungal,
pubmed-meshheading:21050800-Europe,
pubmed-meshheading:21050800-Fluconazole,
pubmed-meshheading:21050800-Humans,
pubmed-meshheading:21050800-Microbial Sensitivity Tests,
pubmed-meshheading:21050800-Species Specificity,
pubmed-meshheading:21050800-United States
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.
|
| pubmed:affiliation |
University of Iowa, Iowa City, IA, USA. michael-pfaller@uiowa.edu
|
| pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|